|
TTC14 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.71970004692446E-09 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.66550000013643E-07 |
| Normal-vs-Stage2 |
3.259000E-03 |
| Normal-vs-Stage3 |
1.203170E-03 |
| Normal-vs-Stage4 |
6.583100E-04 |
| Stage1-vs-Stage2 |
6.260000E-01 |
| Stage1-vs-Stage3 |
4.936200E-01 |
| Stage1-vs-Stage4 |
9.691200E-01 |
| Stage2-vs-Stage3 |
3.655400E-01 |
| Stage2-vs-Stage4 |
6.773800E-01 |
| Stage3-vs-Stage4 |
5.847800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.79959999960333E-07 |
| Normal-vs-AfricanAmerican |
1.92931999999368E-05 |
| Normal-vs-Asian |
9.620100E-02 |
| Caucasian-vs-AfricanAmerican |
1.406470E-02 |
| Caucasian-vs-Asian |
4.169200E-01 |
| AfricanAmerican-vs-Asian |
7.434200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.81879999999946E-05 |
| Normal-vs-Female |
1.47849954501567E-10 |
| Male-vs-Female |
3.460500E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.699600E-02 |
| Normal-vs-Age(41-60Yrs) |
1.90420001988656E-09 |
| Normal-vs-Age(61-80Yrs) |
1.784210E-04 |
| Normal-vs-Age(81-100Yrs) |
5.602300E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.363000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.658600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.842000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.280300E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.725600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.317400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
4.401700E-03 |
| Normal-vs-Grade 2 |
3.55300000531855E-08 |
| Normal-vs-Grade 3 |
4.48960000000165E-05 |
| Normal-vs-Grade 4 |
2.394100E-02 |
| Grade 1-vs-Grade 2 |
6.512300E-02 |
| Grade 1-vs-Grade 3 |
8.764200E-03 |
| Grade 1-vs-Grade 4 |
9.776700E-03 |
| Grade 2-vs-Grade 3 |
1.332250E-01 |
| Grade 2-vs-Grade 4 |
1.231640E-01 |
| Grade 3-vs-Grade 4 |
5.846800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.80519999451556E-08 |
| Normal-vs-ccB subtype |
1.598010E-03 |
| ccA subtype-vs-ccB subtype |
4.541900E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.67659999994463E-07 |
| Normal-vs-N1 |
3.445200E-01 |
| N0-vs-N1 |
3.445600E-01 |
|
|
